Decreased plasmatic spermidine and increased spermine in mild cognitive impairment and Alzheimer's disease patients (2019)
- Authors:
- USP affiliated authors: FORLENZA, ORESTES VICENTE - FM ; GATTAZ, WAGNER FARID - FM
- Unidade: FM
- DOI: 10.1590/0101-60830000000209
- Subjects: DOENÇA DE ALZHEIMER; COMPROMETIMENTO COGNITIVO LEVE; AMINAS (COMPOSTOS ORGÂNICOS); PLASMA; BIOMARCADORES; IDOSOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Archives of clinical psychiatry
- ISSN: 0101-6083
- Volume/Número/Paginação/Ano: v. 46, n. 5, p. 120-124, 2019
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
JOAQUIM, Helena P. G et al. Decreased plasmatic spermidine and increased spermine in mild cognitive impairment and Alzheimer's disease patients. Archives of clinical psychiatry, v. 46, n. 5, p. 120-124, 2019Tradução . . Disponível em: https://doi.org/10.1590/0101-60830000000209. Acesso em: 25 jan. 2026. -
APA
Joaquim, H. P. G., Costa, A. C., Forlenza, O. V., Gattaz, W. F., & Talib, L. L. (2019). Decreased plasmatic spermidine and increased spermine in mild cognitive impairment and Alzheimer's disease patients. Archives of clinical psychiatry, 46( 5), 120-124. doi:10.1590/0101-60830000000209 -
NLM
Joaquim HPG, Costa AC, Forlenza OV, Gattaz WF, Talib LL. Decreased plasmatic spermidine and increased spermine in mild cognitive impairment and Alzheimer's disease patients [Internet]. Archives of clinical psychiatry. 2019 ; 46( 5): 120-124.[citado 2026 jan. 25 ] Available from: https://doi.org/10.1590/0101-60830000000209 -
Vancouver
Joaquim HPG, Costa AC, Forlenza OV, Gattaz WF, Talib LL. Decreased plasmatic spermidine and increased spermine in mild cognitive impairment and Alzheimer's disease patients [Internet]. Archives of clinical psychiatry. 2019 ; 46( 5): 120-124.[citado 2026 jan. 25 ] Available from: https://doi.org/10.1590/0101-60830000000209 - Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease
- Diagnosis and biomarkers of predementia in Alzheimer’s disease
- Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study
- Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein
- Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype
- Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression
- Inhibition of phospolipase A2 modulates glycogen synthase activity and tau phosphorylation in primary cultures of cortical and hippocampal neurons
- Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients
- Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study
- Reduced Cerebrospinal Fluid Levels of Brain-Derived Neurotrophic Factor Is Associated With Cognitive Impairment in Late-Life Major Depression
Informações sobre o DOI: 10.1590/0101-60830000000209 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
